THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Stavros Stavrakis and Sunny Po.
Connection Strength

10.249
  1. TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial. JACC Clin Electrophysiol. 2020 03; 6(3):282-291.
    View in: PubMed
    Score: 0.706
  2. Slow/Fast Atrioventricular Nodal Reentrant Tachycardia Using the Inferolateral Left Atrial Slow Pathway: Role of the Resetting Response to Select the Ablation Target. Circ Arrhythm Electrophysiol. 2018 09; 11(9):e006631.
    View in: PubMed
    Score: 0.641
  3. Ganglionated Plexi Ablation: Physiology and Clinical Applications. Arrhythm Electrophysiol Rev. 2017 Dec; 6(4):186-190.
    View in: PubMed
    Score: 0.608
  4. Low-Level Vagus Nerve Stimulation Suppresses Post-Operative Atrial Fibrillation and Inflammation: A Randomized Study. JACC Clin Electrophysiol. 2017 09; 3(9):929-938.
    View in: PubMed
    Score: 0.587
  5. Spectral Analysis of Baseline Electrocardiogram During Atrial Fibrillation Predicts Response to Antiarrhythmic Drug Therapy in Patients With Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol. 2016 Nov; 27(11):1312-1318.
    View in: PubMed
    Score: 0.559
  6. Spectral Analysis of Electrocardiograms in Patients with Inducible Atrial Fibrillation after Catheter Ablation Predicts Sinus Rhythm Maintenance. Ann Noninvasive Electrocardiol. 2017 Jan; 22(1).
    View in: PubMed
    Score: 0.548
  7. Reply: Vagal Modulation of Atrial Fibrillation. J Am Coll Cardiol. 2015 Aug 25; 66(8):978.
    View in: PubMed
    Score: 0.520
  8. Neuroimmunomodulation: A new frontier of treating cardiovascular diseases. Trends Cardiovasc Med. 2016 Jan; 26(1):12-3.
    View in: PubMed
    Score: 0.507
  9. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol. 2015 Mar 10; 65(9):867-75.
    View in: PubMed
    Score: 0.503
  10. Risk of coronary artery injury with radiofrequency ablation and cryoablation of epicardial posteroseptal accessory pathways within the coronary venous system. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):113-9.
    View in: PubMed
    Score: 0.463
  11. Inhibition of atrial fibrillation by low-level vagus nerve stimulation: the role of the nitric oxide signaling pathway. J Interv Card Electrophysiol. 2013 Apr; 36(3):199-208.
    View in: PubMed
    Score: 0.429
  12. Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation. J Cardiovasc Electrophysiol. 2012 Jul; 23(7):771-7.
    View in: PubMed
    Score: 0.411
  13. Autonomic modulation: an emerging paradigm for the treatment of cardiovascular diseases. Circ Arrhythm Electrophysiol. 2012 Apr; 5(2):247-8.
    View in: PubMed
    Score: 0.411
  14. Non-invasive Neuromodulation of Arrhythmias. Card Electrophysiol Clin. 2024 Sep; 16(3):307-314.
    View in: PubMed
    Score: 0.232
  15. Autonomic Nervous System and Cardiac?Metabolism: Links Between Autonomic and Metabolic Remodeling in Atrial?Fibrillation. JACC Clin Electrophysiol. 2023 Mar 31.
    View in: PubMed
    Score: 0.220
  16. The impact of the clinical diagnosis on the vagal response and heart rate after ganglionated plexus ablation. J Interv Card Electrophysiol. 2022 Jun 25.
    View in: PubMed
    Score: 0.209
  17. Effects of Low-Level Tragus Stimulation on Endothelial Function in Heart Failure With Reduced Ejection Fraction. J Card Fail. 2021 05; 27(5):568-576.
    View in: PubMed
    Score: 0.188
  18. Atrioventricular junctional ablation: The good, the bad, the better. Heart Rhythm O2. 2020 Oct; 1(4):311-314.
    View in: PubMed
    Score: 0.182
  19. Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans. J Cardiovasc Transl Res. 2019 06; 12(3):221-230.
    View in: PubMed
    Score: 0.163
  20. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction. Exp Physiol. 2019 01; 104(1):28-38.
    View in: PubMed
    Score: 0.163
  21. Effect of 28-mm Cryoballoon Ablation on Major Atrial Ganglionated Plexi. JACC Clin Electrophysiol. 2018 06; 4(6):831-838.
    View in: PubMed
    Score: 0.155
  22. Smartphone-based arrhythmia monitoring. Curr Opin Cardiol. 2017 01; 32(1):53-57.
    View in: PubMed
    Score: 0.143
  23. Intermittent vs. Continuous Anticoagulation theRapy in patiEnts with Atrial Fibrillation (iCARE-AF): a randomized pilot study. J Interv Card Electrophysiol. 2017 Jan; 48(1):51-60.
    View in: PubMed
    Score: 0.140
  24. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol. 2016 07; 27(7):827-32.
    View in: PubMed
    Score: 0.136
  25. Ablation of Ventricular Tachycardia in Patients with Ischemic Cardiomyopathy. Card Electrophysiol Clin. 2016 Mar; 8(1):121-9.
    View in: PubMed
    Score: 0.133
  26. A case series and review of the literature regarding coronary artery complications associated with coronary sinus catheter ablation. HeartRhythm Case Rep. 2015 Sep; 1(5):315-319.
    View in: PubMed
    Score: 0.128
  27. The role of the autonomic ganglia in atrial fibrillation. JACC Clin Electrophysiol. 2015 Mar-Apr; 1(1-2):1-13.
    View in: PubMed
    Score: 0.126
  28. Low-level vagosympathetic trunk stimulation inhibits atrial fibrillation in a rabbit model of obstructive sleep apnea. Heart Rhythm. 2015 Apr; 12(4):818-24.
    View in: PubMed
    Score: 0.124
  29. The use of low-level electromagnetic fields to suppress atrial fibrillation. Heart Rhythm. 2015 Apr; 12(4):809-17.
    View in: PubMed
    Score: 0.124
  30. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm. 2013 Mar; 10(3):428-35.
    View in: PubMed
    Score: 0.107
  31. The atrial neural network as a substrate for atrial fibrillation. J Interv Card Electrophysiol. 2012 Oct; 35(1):3-9.
    View in: PubMed
    Score: 0.104
  32. Transesophageal echocardiographic assessment of pulmonary veins and left atrium in patients undergoing atrial fibrillation ablation. Echocardiography. 2011 Aug; 28(7):775-81.
    View in: PubMed
    Score: 0.098
  33. Pseudo-vagal Responses Elicited by Cryoballoon Ablation. J Innov Card Rhythm Manag. 2023 Dec; 14(12):5690-5696.
    View in: PubMed
    Score: 0.058
  34. Outcomes of Catheter Ablation for Atrial Fibrillation in Patients With Rheumatic Mitral Valve Disease. Am J Cardiol. 2024 Jan 01; 210:273-275.
    View in: PubMed
    Score: 0.057
  35. The effect of weight loss on recurrence of atrial fibrillation after catheter ablation: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023 Oct 03.
    View in: PubMed
    Score: 0.057
  36. Psychosocial risk factors and outcomes in patients undergoing catheter ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2023 Sep 11.
    View in: PubMed
    Score: 0.057
  37. Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Europace. 2023 07 04; 25(7).
    View in: PubMed
    Score: 0.056
  38. Same-day discharge for left atrial appendage occlusion procedure: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023 May; 34(5):1196-1205.
    View in: PubMed
    Score: 0.055
  39. Antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2023 Mar 16.
    View in: PubMed
    Score: 0.055
  40. Impact of low-level electromagnetic fields on the inducibility of atrial fibrillation in the electrophysiology laboratory. Heart Rhythm O2. 2021 Jun; 2(3):239-246.
    View in: PubMed
    Score: 0.048
  41. A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation. Int J Cardiol. 2018 Mar 15; 255:92-98.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES